Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Rehabilitation on Functional Outcomes in Patients With SOD1 ALS Treated With Tofersen

NCT05725759 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05725759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05725759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Rehabilitation on Functional Outcomes in Patients With SOD1 ALS Treated With Tofersen
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Unknown status
Start date
November 8, 2022
Completion date
December 31, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, familial amyotrophic lateral sclerosis, lou gehrig disease, motor neuron disease, motor neuron disease, familial